Trade Henry Schein, Inc. - HSIC CFD

Henry Schein Company profile

About Henry Schein, Inc.

Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company’s segments include Health care distribution and Technology and value-added services. The Health care distribution segment distributes consumable products, laboratory products, equipment repair services, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions, medical practitioners and ambulatory surgery centers. The Technology and value-added services segments provides software, technology and other value-added services to health care practitioners. It also offers practice management software systems for dental and medical practitioners. The Company's value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services.

Financial summary

BRIEF: For the fiscal year ended 25 December 2021, Henry Schein, Inc. revenues increased 23% to $12.4B. Net income before extraordinary items increased 57% to $631.2M. Revenues reflect Dental segment increase of 28% to $7.54B, Medical segment increase of 17% to $4.22B, Technology and value-added services segment increase of 25% to $640.9M, United States segment increase of 23% to $8.72B, International segment increase of 21% to $3.68B.

Equity composition

Common Stock $.01 Par, 04/11, 240M auth., 92,251,522 o/s. Insiders & Strategic holders own 1.42%. IPO 11/95, 6,165,000 shs. @ $16 by William Blair. *FY'00 Q's are reclassified. 3/05, 2-for-1 stock split.